332 related articles for article (PubMed ID: 21332734)
61. Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.
Koka S; Clarke BL; Amin S; Gertz M; Ruggiero SL
Int J Prosthodont; 2007; 20(2):115-22. PubMed ID: 17455429
[TBL] [Abstract][Full Text] [Related]
62. Bisphosphonates and osteonecrosis of the jaw.
Sambrook P; Olver I; Goss A
Aust Fam Physician; 2006 Oct; 35(10):801-3. PubMed ID: 17019456
[TBL] [Abstract][Full Text] [Related]
63. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
Lee J
J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
[TBL] [Abstract][Full Text] [Related]
64. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment.
Fehm T; Felsenberg D; Krimmel M; Solomayer E; Wallwiener D; Hadjii P
Breast; 2009 Aug; 18(4):213-7. PubMed ID: 19651512
[TBL] [Abstract][Full Text] [Related]
65. Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws.
Lehrer S; Montazem A; Ramanathan L; Pessin-Minsley M; Pfail J; Stock RG; Kogan R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Sep; 106(3):389-91. PubMed ID: 18554944
[TBL] [Abstract][Full Text] [Related]
66. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
Abu-Id MH; Warnke PH; Gottschalk J; Springer I; Wiltfang J; Acil Y; Russo PA; Kreusch T
J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
[TBL] [Abstract][Full Text] [Related]
67. Dental endosseous implants in patients on bisphosphonate therapy.
Scully C; Madrid C; Bagan J
Implant Dent; 2006 Sep; 15(3):212-8. PubMed ID: 16966893
[TBL] [Abstract][Full Text] [Related]
68. Bisphosphonate-induced osteonecrosis: dental considerations.
Gross HB
Compend Contin Educ Dent; 2008 Mar; 29(2):112-3. PubMed ID: 18429426
[No Abstract] [Full Text] [Related]
69. Bisphosphonate osteonecrosis of the jaw--a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention.
Patel V; McLeod NM; Rogers SN; Brennan PA
Br J Oral Maxillofac Surg; 2011 Jun; 49(4):251-7. PubMed ID: 20605289
[TBL] [Abstract][Full Text] [Related]
70. Bisphosphonates and osteonecrosis of the jaw: proceedings of an international conference.
Bilezikian JP; Grbic JT
Ann N Y Acad Sci; 2011 Feb; 1218():1-2. PubMed ID: 21291476
[TBL] [Abstract][Full Text] [Related]
71. Antiresorptive drug-related osteonecrosis of the jaw.
Uyanne J; Calhoun CC; Le AD
Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
[TBL] [Abstract][Full Text] [Related]
72. [Osteonecrosis of the jaw].
Drozdzowska B
Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
[TBL] [Abstract][Full Text] [Related]
73. Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.
Wehrhan F; Hyckel P; Amann K; Ries J; Stockmann P; Schlegel K; Neukam F; Nkenke E
Oral Dis; 2011 May; 17(4):433-42. PubMed ID: 21366807
[TBL] [Abstract][Full Text] [Related]
74. Bisphosphonate-associated osteonecrosis of the jaw: a literature review and clinical practice guidelines.
Pickett FA;
J Dent Hyg; 2006; 80(3):10. PubMed ID: 16953991
[TBL] [Abstract][Full Text] [Related]
75. Recent recommendations on bisphosphonate-associated osteonecrosis of the jaw.
Arrain Y; Masud T
Dent Update; 2008 May; 35(4):238-40, 242. PubMed ID: 18557500
[TBL] [Abstract][Full Text] [Related]
76. Osteonecrosis of the jaw.
Drozdzowska B
Endokrynol Pol; 2011; 62(1):88-92. PubMed ID: 21365586
[TBL] [Abstract][Full Text] [Related]
77. Potential pathophysiological mechanisms in osteonecrosis of the jaw.
Landesberg R; Woo V; Cremers S; Cozin M; Marolt D; Vunjak-Novakovic G; Kousteni S; Raghavan S
Ann N Y Acad Sci; 2011 Feb; 1218():62-79. PubMed ID: 21291478
[TBL] [Abstract][Full Text] [Related]
78. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
Campisi G; Fedele S; Colella G; Lo Casto A; Fusco V
J Rheumatol; 2009 Feb; 36(2):451-3; author reply 453. PubMed ID: 19208579
[No Abstract] [Full Text] [Related]
79. [Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review].
Capsoni F
Reumatismo; 2008; 60(1):6-13. PubMed ID: 18432320
[TBL] [Abstract][Full Text] [Related]
80. [Bisphosphonate-related osteonecrosis of the jaws].
van der Waal I
Ned Tijdschr Tandheelkd; 2012 Apr; 119(4):206-11. PubMed ID: 22567818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]